Show simple item record

 
dc.contributorDepartament de Salut
dc.date.accessioned2018-11-16T12:48:18Z
dc.date.available2018-11-16T12:48:18Z
dc.date.issued2018-01-17
dc.identifier.citationCarfilzomib: en combinació amb lenalidomida i dexametasona o dexametasona sola, per al tractament de pacients adults amb mieloma múltiple que han rebut com a mínim un tractament previ. Barcelona: Servei Català de la Salut; 2018.
dc.identifier.urihttp://hdl.handle.net/11351/3661
dc.descriptionCarfilzomib; Lenalidomide; Adult patients
dc.description.abstractMultiple myeloma (MM) is a neoplastic disorder. With current treatments it is considered an incurable clinical condition. The main goals of the treatment are to prolong survival and maintain the quality of life by controlling the illness and the relief of symptoms. There is a medical need not covered by better treatments capable of delaying the progression of the MM, given the absence of a healing treatment and that in the long run patients will become refractory to treatment. The choice of treatment in the context of relapse depends on many parameters such as age, functional status, comorbidities, type, efficacy and tolerance of previous treatment, number of treatment lines, options Of remaining available treatment, the interval from the last treatment and the type of relapse
dc.language.isocat
dc.publisherServei Català de la Salut
dc.relation.ispartofPrograma d'harmonització farmacoteràpeutica, Servei Català de la Salut
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectMieloma múltiple - Tractament
dc.subjectDexametasona - Ús terapèutic
dc.subjectMedicaments - Assaigs clínics
dc.subject.meshMultiple Myeloma
dc.subject.mesh/drug therapy
dc.subject.meshDrug Evaluation
dc.titleCarfilzomib: en combinació amb lenalidomida i dexametasona o dexametasona sola, per al tractament de pacients adults amb mieloma múltiple que han rebut com a mínim un tractament previ
dc.typeinfo:eu-repo/semantics/report
dc.subject.decsmieloma múltiple
dc.subject.decs/tratamiento farmacológico
dc.subject.decsevaluación de medicamentos
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record